SNGX Return on Tangible Equity | SOLIGENIX, INC.

SOLIGENIX, INC. (SNGX) Return on Tangible Equity

2026-06-30: Return Tang Equity -154.22%.
2026-03-31: Return Tang Equity -355.21%.
2025-12-31: Return Tang Equity -209.62%.
2025-09-30: Return Tang Equity -147.15%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-154.22%
2026-03-31	-355.21%
2025-12-31	-209.62%
2025-09-30	-147.15%
2025-06-30	-568.35%
2025-03-31	-239.03%
2024-12-31	-201.04%
2024-09-30	-119.73%
2024-06-30	-203.62%
2024-03-31	-919.63%
2023-12-31	-244.04%
2023-09-30	-191.56%
2023-06-30	-167.77%
2023-03-31	309.31%
2022-12-31	557.07%
2022-09-30	-1437.65%
2022-06-30	-357.81%
2022-03-31	-220.99%
2021-12-31	-117.12%
2021-09-30	-88.96%
2021-06-30	-74.34%
2021-03-31	-72.03%
2020-12-31	-473.50%
2020-09-30	-202.99%
2020-06-30	-264.76%
2020-03-31	-436.85%
2019-12-31	-650.85%
2019-09-30	-361.70%
2019-06-30	-242.29%
2019-03-31	-155.73%
2018-12-31	-142.78%
2018-09-30	-86.10%
2018-06-30	-274.56%
2018-03-31	-194.62%
2017-12-31	-114.43%
2017-09-30	-174.22%
2017-06-30	-171.53%
2017-03-31	-67.12%
2016-12-31	-44.64%
2016-09-30	-245.25%
2016-06-30	424.50%
2016-03-31	360.51%
2015-12-31	3782.45%
2015-09-30	541.56%
2015-06-30	287.23%
2015-03-31	364.14%
2014-12-31	1189.52%
2014-09-30	161.04%
2014-06-30	189.84%
2014-03-31	262.66%
2013-12-31	418.72%
2013-09-30	280.95%
2013-06-30	-364.80%
2013-03-31	-214.69%
2012-12-31	-154.45%
2012-09-30	-132.17%
2012-06-30	-31.42%
2012-03-31	-47.65%
2011-12-31	-41.65%
2011-09-30	-45.14%
2011-06-30	-165.36%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-210.16%
2024-12-31	-201.70%
2023-12-31	-245.36%
2022-12-31	554.03%
2021-12-31	-117.27%
2020-12-31	-475.23%
2019-12-31	-650.85%
2018-12-31	-142.78%
2017-12-31	-114.43%
2016-12-31	-44.64%
2015-12-31	3782.45%
2014-12-31	1189.52%
2013-12-31	418.72%
2012-12-31	-154.45%
2011-12-31	-41.65%
2010-12-31	-100.39%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Imunon, Inc. (IMNN)	United States	$0.008B	-0.56
EXICURE, INC. (XCUR)	United States	$0.008B	-1.54
Traws Pharma, Inc. (TRAW)	United States	$0.009B	-0.58
Alzamend Neuro, Inc. (ALZN)	United States	$0.009B
Ensysce Biosciences, Inc. (ENSC)	United States	$0.008B	-0.37
InMed Pharmaceuticals Inc. (INM)		$0.008B	-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)	United States	$0.008B
FibroBiologics, Inc. (FBLG)	United States	$0.009B	-0.27
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)	United States	$0.007B	-0.97